Inactive Instrument
Kadimastem Stock OTC Markets
Stocks
KMSTF
IL0011284614
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 53.88M 17.59M 15.71M 14.61M 13.29M 25.1M 1.7B 25.2M 176M 68.91M 868M 66.05M 64.6M 2.78B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 53.88M 17.59M 15.71M 14.61M 13.29M 25.1M 1.7B 25.2M 176M 68.91M 868M 66.05M 64.6M 2.78B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
34.42% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -0.78% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.78% | +153.00% | - | - | 17.59M | |
| -2.59% | -5.70% | +50.69% | +86.86% | 70.61B | |
| +3.23% | -10.67% | +6.27% | +53.70% | 51.01B | |
| +1.56% | +1.17% | +8.49% | +31.81% | 48.1B | |
| +0.39% | +0.65% | +31.14% | +28.97% | 42.78B | |
| +0.87% | -8.17% | +293.37% | +642.41% | 40.67B | |
| +1.24% | -1.01% | +10.74% | +100.64% | 40.3B | |
| -2.13% | -1.64% | +8.63% | +46.88% | 30.59B | |
| -0.46% | -1.28% | +42.23% | +20.34% | 28.16B | |
| +5.32% | +0.06% | -5.00% | -12.78% | 24.36B | |
| Average | +0.67% | -2.66% | +49.62% | +110.98% | 41.84B | |
| Weighted average by Cap. | +0.56% | -2.94% | +51.35% | +115.57% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | - | - |
| Net Debt | - | - |
Employees
11
